Advertisement

Palliation and Benign Conditions

  • Stuart Y. Tsuji
  • William M. Wara
Chapter

Abstract

This chapter will cover brain metastases, bone metastases, spinal cord compression, liver metastases, airway obstruction, superior vena cava obstruction, and gynecologic bleeding.

Keywords

Brain Metastasis Spinal Cord Compression Metastatic Spinal Cord Compression Superior Vena Cava Obstruction Radiation Myelopathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

References

  1. Andrews DW, Scott CB, Sperduto PW, et al. Whole Brain Radiation Therapy with or without Stereotactic Radiosurgery Boost for Patients with One to Three Brain Metastases: Phase III Results of the RTOG 9508 Randomised Trial. Lancet 2004;363:1665-1672.PubMedCrossRefGoogle Scholar
  2. Aoyama H, Shirato H, Tago M, et al. Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases: A Randomized Controlled Trial. JAMA 2006;295(21):2483-2491.PubMedCrossRefGoogle Scholar
  3. Blitzer PH. Reanalysis of the RTOG Study of the Palliation of Symptomatic Osseous Metastasis. Cancer 1985;55:1468-1472.PubMedCrossRefGoogle Scholar
  4. Bone Pain Trial Working Party. 8 Gy Single Fraction Radiotherapy for the treatment of Metastatic Skeletal Pain: Randomised Comparison with a Multifraction Schedule over 12 Months of Patient Follow-Up. Radiother Oncol 1999;52:111-121.CrossRefGoogle Scholar
  5. Borgelt B, Gelber R, Kramer S, et al. The Palliation of Brain Metastases: Final Results fo the First Two Studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980;6:1-9.PubMedCrossRefGoogle Scholar
  6. Borgelt B, Gelber R, Larson M, et al. Ultra-Rapid High Dose Irradiation Schedules for the Palliarion of Brain Metastases: Final Results of the First Two Studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981;7:1633-1638.PubMedCrossRefGoogle Scholar
  7. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009;10:1037-1044.PubMedCrossRefGoogle Scholar
  8. Chow E, Harris K, et al. Palliative Radiotherapy Trials for Bone Metastases: a Systematic Review. J Clin Oncol 2007;25:1423-1436.PubMedCrossRefGoogle Scholar
  9. Gaspar L, Scott C, Rotman M, et al. Recursive Partitioning Analysis (RPA) of Prognostic Factors in Three Radiation Therapy Oncology Group (RTOG) Brain Metastases Trials. Int J Radiat Oncol Biol Phys 1997;37:745-751.PubMedCrossRefGoogle Scholar
  10. Gerszten PC, Burton SA, Ozhasoglu C. Radiosurgery for Spinal Metastases: Clinical Experience in 500 Cases from a Single Institution. Spine 2007;32:193-199.PubMedCrossRefGoogle Scholar
  11. Hartsell WF, Scott CB, Bruner DW, et al. Randomized Trial of Short- Versus Long-Course Radiotherapy for Palliation of Painful Bone Metastases. J Natl Cancer Inst 2005;97:798-804.PubMedCrossRefGoogle Scholar
  12. Howell DD, James JL, Hartsell WF, et al. Randomized Trial of Short-Course Versus Long-Course Radiotherapy for Palliation of Painful Vertebral Bone Metastases: A Retrospective Analysis of RTOG 97-14. J Clin Oncol 2009;27:7s. ASCO 2009, abstract.Google Scholar
  13. Kondziolka D, Patel A, Lunsford LD, et al. Stereotactic Radiosurgery Plus Whole Brain Radiotherapy Versus Radiotherapy Alone for Patients with Multiple Brain Metastases. Int J Radiat Oncol Biol Phys 1999;45:427-434.PubMedCrossRefGoogle Scholar
  14. McCarter MD, Fong Y. Metastatic Liver Tumors. Semin Surgl Oncol 2000; 19:177-188.CrossRefGoogle Scholar
  15. Mehta MP, Shapiro WR, Phan SC, et al. Motexafin Gadolinium Combined with Prompt Whole Brain Radiotherapy Prolongs Time to Neurologic Progression in Non-Small-Cell Lung Cancer Patients with Brain Metastases: Results of a Phase III Trial. Int J Radiat Oncol Biol Phys 2009;73:1069-1076.PubMedCrossRefGoogle Scholar
  16. Mirels H. Metastatic Disease in Long Bones. A Proposed Scoring System for Diagnosing Impending Pathologic Fractures. Clin Orthop Relat Res 1989; 249:256-264.Google Scholar
  17. Mueller RP, Soffietti R, Abacioglu MU, et al. Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of 1-3 Cerebral Metastases: Results of the EORTC 22952-26001 Study. J Clin Oncol 2009;27:15s. ASCO 2009, abstract.Google Scholar
  18. Murrary KJ, Scott C, Greenberg HM, et al. A Randomized Phase III Study of Accelerated Hyperfractionation Versus Standard in Patients with Unresected Brain Metastases: A Report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 1997;39:571-574.CrossRefGoogle Scholar
  19. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain. JAMA 1998;280:1485-1489.PubMedCrossRefGoogle Scholar
  20. Patchell RA, Tibbs PA, Regine WF, et al. Direct Decompressive Surgical Resection in the Treatment of Spinal Cord Compression Caused by Metastatic Cancer: A Randomised Trial. Lancet 2005;366:643-648.PubMedCrossRefGoogle Scholar
  21. Patchell RA, Tibbs PA, Walsh JW, et al. A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain. N Engl J Med 1990;322:494-500.PubMedCrossRefGoogle Scholar
  22. Porter AT, McEwan AJ, Powe JE, et al. Results of a Randomized Phase III Trial to Evaluate the Efficacy of Strontium-89 Adjuvant to Local Field External Beam Irradiation in the Management of Endocrine Resistant Metastatic Prostate Cancer. Int J Radiat Oncol Biol Phys 1993;25:805-813.PubMedCrossRefGoogle Scholar
  23. Rades D, Lange M, Veninga T, et al. Final Results of A Study Comparing Short-Course and Long-Course Radiotherapy (RT) for Local Control of Metastatic Spinal Cord Compression (MSCC). J Clin Oncol 2009;27:7s. ASCO 2009, abstract.Google Scholar
  24. Rades D, Rudat V, Veninga T, et al. Prognostic Factors for Functional Outcome and Survival After Reirradiation for In-Field Recurrences of Metastatic Spinal Cord Compression. Cancer 2008;113:1090-1096.PubMedCrossRefGoogle Scholar
  25. Rades D, Stalpers LJA, Hulshof MC, et al. Comparison of 1 x 8 Gy and 10 x 3 Gy for Functional Outcome in Patients with Metastatic Spinal Cord Compression. Int J Radiat Oncol Biol Phys 2005;62:514-518.PubMedCrossRefGoogle Scholar
  26. Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases. J Clin Oncol 2009;27(10):1572-1578.PubMedCrossRefGoogle Scholar
  27. Sahgal A, Ames C, Chou D, et al. Stereotactic Body Radiotherapy is Effective Salvage Therapy for Patients with Prior Radiation of Spinal Metastases. Int J Radiat Oncol Biol Phys 2009;74(3): 723-731.PubMedCrossRefGoogle Scholar
  28. Sartor O, Reid RH, Hoskin PJ, et al. Samarium-153-Lexidronam Complex for Treatment of Painful Bone Metastases in Hormone-Refractory Prostate Cancer. Urology 2004;63:940-945.PubMedCrossRefGoogle Scholar
  29. Sciuto R, Festa A, Rea S, et al. Effects of Low-Dose Cisplatin on 89Sr Therapy for Painful Bone Metastases from Prostate Cancer: A Randomized Clinical Trial. J Nucl Med 2002;43:79-86.PubMedGoogle Scholar
  30. Shaw E, Scott C, Souhami L, et al. Single Dose Radiosurgical Treatment of Recurrent previously Irradiated Primary Brain Tumors and Brain Metastases: Final Report of RTOG Protocol 90-05. Int J Radiat Oncol Biol Phys 2000;47:291-298.PubMedCrossRefGoogle Scholar
  31. Sneed PK, Lamborn KR, Forstner JM, et al. Radiosurgery for Brain Metastases: Is Whole Brain Radiotherapy Necessary? Int J Radiat Oncol Biol Phys 1999;43:549-558.PubMedCrossRefGoogle Scholar
  32. Sneed PK, Suh JH, Goetsch SJ, et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 2002;53:519-526.PubMedCrossRefGoogle Scholar
  33. Sperduto PW, Berkey B, Gaspar LE, et al. A New Prognostic Index and Comparison to Three Other Indices for Patients with Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database. Int J Radiat Oncol Biol Phys 2008;70:510-514.PubMedCrossRefGoogle Scholar
  34. Suh JH, Stea B, Nabid A, et al. Phase III Study of Efaproxiral As an Adjunct to Whole-Brain Radiation Therapy for Brain Metastases. J Clin Oncol 2006;24:106-114.PubMedCrossRefGoogle Scholar
  35. Tong D, Gillick L, Hendrickson FR. The Palliation of Symptomatic Osseous Metastases: Final Results of the Study by the Radiation Therapy Oncology Group. Cancer 1982;50:893-899.PubMedCrossRefGoogle Scholar
  36. Van der Linden YM, Dijkstra PD, Kroon HM, et al. Comparative Analysis of Risk Factors for Pathological Fracture with Femoral Metastases. J Bone Joint Surg Br 2004;86:566-573.PubMedGoogle Scholar

Further Reading

  1. Cowper SE. Nephrogenic Systemic Fibrosis: An Overview. J Am Coll Radiol 2008;5:23-28.PubMedCrossRefGoogle Scholar
  2. Dillehay GL, Ellerbroek NA, Balon H, et al. Practice Guideline for the Performance of Therapy with Unsealed Radiopharmaceutical Sources. Int J Radiat Oncol Biol Phys 2006;64:1299-1307.PubMedCrossRefGoogle Scholar
  3. Finlay IG, Mason MD, Shelley M. Radioisotopes for the Palliation of Metastatic Bone Cancer: A Systematic Review. Lancet Oncol 2005;6:392-400.PubMedCrossRefGoogle Scholar
  4. Janjan NA, Delclos ME, Ballo MT, et al. Palliative Care. In: Cox JD, Ang KK, editors. Radiation Oncology: Rationale, Technique, Results. 8th ed. St. Louis: Mosby; 2003. pp. 954-986.Google Scholar
  5. Johnson JD, Young B. Demographics of Brain Metastasis. Neurosurg Clin North Am 1996;7:337-344.Google Scholar
  6. Kagan RA. Palliation of Brain and Spinal Cord Metastases. In: Perez CA, Brady LW, Halperin EC, et al, editors. Principles and Practice of Radiation Oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. pp. 2373-2384.Google Scholar
  7. Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005;23:2038-2048.PubMedCrossRefGoogle Scholar
  8. Oosterhof G, Roberts JT, de Reijke TM, et al. Strontium89 Chloride Versus Palliative Local Field Radiotherapy in Patients with Hormonal Escaped Prostate Cancer: A Phase III Study of the European Organisation for Research and Treatment of Cancer Genitourinary Group. Eur Urol 2003;44:519-526.PubMedCrossRefGoogle Scholar
  9. Perez CA, Grigsby PW, Thorstad W. Nonsealed Radionuclide Therapy. In: Perez CA, Brady LW, Halperin EC, et al, editors. Principles and Practice of Radiation Oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. pp. 636-652.Google Scholar
  10. Porter AT, Benda R, Ben-Josef E. Palliation of Metasteses: Bone and Spinal Cord. In: Gunderson LL, Tepper JE, editors. Clinical Radiation Oncology. 1st ed. Philadelphia: Churchill Livingstone; 2000. pp. 299-313.Google Scholar
  11. Ratanatharathorn V, Powers WE, Temple HT. Palliation of Bone Metastases. In: Perez CA, Brady LW, Halperin EC, et al, editors. Principles and Practice of Radiation Oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. pp. 2385-2404.Google Scholar
  12. Sahgal A, Larson DA, Chang EL. Stereotactic Body Radiosurgery for Spinal Metastases: A Critical Review. Int J Radiat Oncol Biol Phys 2008;71:652-665.PubMedCrossRefGoogle Scholar
  13. Stevens, KR. The Liver and Biliary System. In: Cox JD, Ang KK, editors. Radiation Oncology: Rationale, Technique, Results. 8th ed. St. Louis: Mosby; 2003. pp. 493-496.Google Scholar

Copyright information

© Springer-Verlag New York 2010

Authors and Affiliations

  • Stuart Y. Tsuji
    • 1
  • William M. Wara
    • 1
  1. 1.Radiation OncologyUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations